Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia.
Saved in:
| Title: | Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia. |
|---|---|
| Authors: | Dijkstra DJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Lokki AI; Department of Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Gierman LM; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Borggreven NV; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., van der Keur C; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Eikmans M; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Gelderman KA; Department of Immunopathology and Haemostasis, Sanquin Diagnostic Services, Amsterdam, Netherlands., Laivuori H; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Department of Obstetrics and Gynecology, Tampere University Hospital and Tampere University, Faculty of Medicine and Health Technology, Tampere Center for Child, Adolescent, and Maternal Health Research, Tampere, Finland., Iversen AC; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., van der Hoorn MP; Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, Netherlands., Trouw LA; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands. |
| Corporate Authors: | FINNPEC Core Investigator Group |
| Source: | Frontiers in immunology [Front Immunol] 2022 Mar 31; Vol. 13, pp. 842451. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35432365 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dijkstra+DJ%22">Dijkstra DJ</searchLink>; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Lokki+AI%22">Lokki AI</searchLink>; Department of Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Gierman+LM%22">Gierman LM</searchLink>; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Borggreven+NV%22">Borggreven NV</searchLink>; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Keur+C%22">van der Keur C</searchLink>; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Eikmans+M%22">Eikmans M</searchLink>; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderman+KA%22">Gelderman KA</searchLink>; Department of Immunopathology and Haemostasis, Sanquin Diagnostic Services, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Laivuori+H%22">Laivuori H</searchLink>; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Department of Obstetrics and Gynecology, Tampere University Hospital and Tampere University, Faculty of Medicine and Health Technology, Tampere Center for Child, Adolescent, and Maternal Health Research, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Iversen+AC%22">Iversen AC</searchLink>; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22van+der+Hoorn+MP%22">van der Hoorn MP</searchLink>; Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Trouw+LA%22">Trouw LA</searchLink>; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22FINNPEC+Core+Investigator+Group%22">FINNPEC Core Investigator Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Mar 31; Vol. 13, pp. 842451. <i>Date of Electronic Publication: </i>2022 Mar 31 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35432365 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.842451 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 842451 Titles: – TitleFull: Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dijkstra DJ – PersonEntity: Name: NameFull: Lokki AI – PersonEntity: Name: NameFull: Gierman LM – PersonEntity: Name: NameFull: Borggreven NV – PersonEntity: Name: NameFull: van der Keur C – PersonEntity: Name: NameFull: Eikmans M – PersonEntity: Name: NameFull: Gelderman KA – PersonEntity: Name: NameFull: Laivuori H – PersonEntity: Name: NameFull: Iversen AC – PersonEntity: Name: NameFull: van der Hoorn MP – PersonEntity: Name: NameFull: Trouw LA IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 03 Text: 2022 Mar 31 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |